Better Context Better Decisions

Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.

novo cover image
$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, GLP-1RA + Basal, Other Aug 14 | 2020Novo Invests in Upgrading Kalundborg Manufacturing FacilityPurchase Blast
$599
Posted in: Glucose Monitoring, Other Aug 12 | 2020DarioHealth Q2 '20 Earnings UpdatePurchase Blast
novo cover image
$599
Posted in: Basal Insulin, Bolus Insulin, Dual/triple agonist, GLP-1RA, GLP-1RA + Basal, Other Aug 07 | 2020Novo Q2 '20 Roadshow; Provention Bio Q2 '20 Earnings Update; Senseonics Eversense Covered by HighmarkPurchase Blast
novo cover image
$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, GLP-1RA + Basal, Other Aug 06 | 2020Novo Discontinues its Dual/Triple Agonists for Obesity; Novo Q2 '20 Earnings UpdatePurchase Blast
lilly cover image
$599
Posted in: Basal Insulin, Bolus Insulin Aug 03 | 2020Lilly Initiates New Connected Pen TrialPurchase Blast
merck cover image
$599
Posted in: DPP-IVi, SGLT2i Jul 31 | 2020Merck Q2 '20 Earnings UpdatePurchase Blast
tandem cover image
$599
Posted in: Insulin Delivery Jul 30 | 2020Tandem Q2 '20 Earnings UpdatePurchase Blast
sanofi cover image
$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA + Basal Jul 29 | 2020Sanofi Q2 '20 Earnings UpdatePurchase Blast
1 2 3 44

Get the Latest Analysis

Stay informed and aligned with frequent updates to keep a pulse on the industry.

If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.